Similar articles for PMID: 28260930

Year	Number of Results
1997	1
2002	1
2003	1
2005	1
2006	1
2007	2
2008	3
2009	1
2010	4
2011	2
2012	5
2013	5
2014	12
2015	9
2016	15
2017	11
2018	11
2019	10
2020	7
2021	7
2022	4
2023	2
2024	0

1

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas.

Recine F, Bongiovanni A, Riva N, Fausti V, De Vita A, Mercatali L, Liverani C, Miserocchi G, Amadori D, Ibrahim T. Recine F, et al. Onco Targets Ther. 2017 Feb 23;10:1155-1164. doi: 10.2147/OTT.S127955. eCollection 2017. Onco Targets Ther. 2017. PMID: 28260930 Free PMC article. Review.

2

Trabectedin in soft tissue sarcomas.

Petek BJ, Loggers ET, Pollack SM, Jones RL. Petek BJ, et al. Mar Drugs. 2015 Feb 12;13(2):974-83. doi: 10.3390/md13020974. Mar Drugs. 2015. PMID: 25686274 Free PMC article. Review.

3

Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options.

Duffaud F, Maki RG, Jones RL. Duffaud F, et al. Expert Rev Clin Pharmacol. 2016 Apr;9(4):501-512. doi: 10.1586/17512433.2016.1152179. Expert Rev Clin Pharmacol. 2016. PMID: 26873304

4

Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.

Grosso F, D'Ambrosio L, Zucchetti M, Ibrahim T, Tamberi S, Matteo C, Rulli E, Comandini D, Palmerini E, Baldi GG, DeCensi A, Bergaglio M, Marra D, Marchesi E, Siri G, D'Incalci M, Grignani G. Grosso F, et al. Cancer. 2020 Nov 1;126(21):4726-4734. doi: 10.1002/cncr.33120. Epub 2020 Aug 4. Cancer. 2020. PMID: 32749681 Free article. Clinical Trial.

5

Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.

Kopp HG, Patel S, Brücher B, Hartmann JT. Kopp HG, et al. Am J Clin Dermatol. 2008;9(4):207-17. doi: 10.2165/00128071-200809040-00001. Am J Clin Dermatol. 2008. PMID: 18572972 Review.

6

The Role of Trabectedin in Soft Tissue Sarcoma.

Nakamura T, Sudo A. Nakamura T, et al. Front Pharmacol. 2022 Feb 23;13:777872. doi: 10.3389/fphar.2022.777872. eCollection 2022. Front Pharmacol. 2022. PMID: 35281940 Free PMC article. Review.

7

[Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].

Kobayashi E, Kawai A. Kobayashi E, et al. Gan To Kagaku Ryoho. 2017 Jun;44(6):468-472. Gan To Kagaku Ryoho. 2017. PMID: 28698435 Japanese.

8

The importance of treating by histological subtype in advanced soft tissue sarcoma.

Martín Broto J, Le Cesne A, Reichardt P. Martín Broto J, et al. Future Oncol. 2017 Jan;13(1s):23-31. doi: 10.2217/fon-2016-0500. Future Oncol. 2017. PMID: 27918201 Review.

9

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin.

Desar IM, Constantinidou A, Kaal SE, Jones RL, van der Graaf WT. Desar IM, et al. Cancer Manag Res. 2016 Aug 17;8:95-104. doi: 10.2147/CMAR.S86746. eCollection 2016. Cancer Manag Res. 2016. PMID: 27574465 Free PMC article. Review.

10

Long-term response to first-line trabectedin in an elderly female patient with a metastatic leiomyosarcoma unfit for anthracycline.

Maruzzo M, Brunello A, Diminutto A, Rastrelli M, Basso U. Maruzzo M, et al. Anticancer Drugs. 2016 Mar;27(3):264-7. doi: 10.1097/CAD.0000000000000326. Anticancer Drugs. 2016. PMID: 26629769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year